These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25698204)

  • 1. Effect of alemtuzumab on intestinal intraepithelial lymphocytes and intestinal barrier function in cynomolgus model.
    Qu LL; Lyu YQ; Jiang HT; Shan T; Zhang JB; Li QR; Li JS
    Chin Med J (Engl); 2015 Mar; 128(5):680-6. PubMed ID: 25698204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-mouse CD52 monoclonal antibody on mouse intestinal intraepithelial lymphocytes.
    Qu L; Li Q; Jiang H; Gu L; Zhang Q; Wang C; Li J
    Transplantation; 2009 Sep; 88(6):766-72. PubMed ID: 19920775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte depletion and repopulation in peripheral blood and small intestine of cynomolgus monkeys after alemtuzumab treatment.
    Shan T; Qu L; Zhang J; Li Q; Shen B; Gu L; Jiang J; Feng X; Li N; Li J
    J Surg Res; 2011 May; 167(1):e21-7. PubMed ID: 20888596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal interaction between intestinal microbiota and mucosal lymphocyte in cynomolgus monkeys after alemtuzumab treatment.
    Li QR; Wang CY; Tang C; He Q; Li N; Li JS
    Am J Transplant; 2013 Apr; 13(4):899-910. PubMed ID: 23433407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.
    Nückel H; Frey UH; Röth A; Dührsen U; Siffert W
    Eur J Pharmacol; 2005 May; 514(2-3):217-24. PubMed ID: 15910809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction.
    Weissenbacher A; Hautz T; Kimelman M; Oberhuber R; Ulmer H; Bösmüller C; Maglione M; Schneeberger S
    J Immunol Res; 2015; 2015():985460. PubMed ID: 26171403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of intestinal intraepithelial lymphocytes in turnover of intestinal epithelial cells: morphological and functional alterations due to daily administration of FK506.
    Hidaka M; Nakamura M; Ohmichi Y; Itoh J; Fukuzawa K; Masuko T; Yagi H
    Cell Immunol; 2012 Oct; 279(2):124-33. PubMed ID: 23228594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of alemtuzumab on the intestinal Paneth cells and microflora in macaques.
    Li Q; Zhang Q; Wang C; Tang C; Zhang Y; Jiang S; Li N; Li J
    Clin Immunol; 2010 Sep; 136(3):375-86. PubMed ID: 20605528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of the variables affecting efficacy of immunodepletion ex vivo of peripheral blood progenitor cell grafts by alemtuzumab (Campath in the bag).
    Novitzky N; Davison G; Abdulla R; Mowla S
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1753-9. PubMed ID: 24120379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses.
    Anderson AE; Lorenzi AR; Pratt A; Wooldridge T; Diboll J; Hilkens CM; Isaacs JD
    Rheumatology (Oxford); 2012 Aug; 51(8):1397-406. PubMed ID: 22447884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine modulates CD8αα(+) TCRαβ(+) intestinal intraepithelial lymphocyte expression in mice with polymicrobial sepsis.
    Tung JN; Lee WY; Pai MH; Chen WJ; Yeh CL; Yeh SL
    Nutrition; 2013 Jun; 29(6):911-7. PubMed ID: 23522839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alemtuzumab induction in deceased donor kidney transplantation.
    Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
    Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders.
    Martin SI; Marty FM; Fiumara K; Treon SP; Gribben JG; Baden LR
    Clin Infect Dis; 2006 Jul; 43(1):16-24. PubMed ID: 16758413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.
    Zanfi C; Lauro A; Cescon M; Dazzi A; Ercolani G; Grazi GL; Zanello M; Vivarelli M; Del Gaudio M; Ravaioli M; Cucchetti A; Vetrone G; Tuci F; Di Gioia P; Lazzarotto T; D'Errico A; Bagni A; Faenza S; Siniscalchi A; Pironi L; Pinna AD
    Transplant Proc; 2010; 42(1):35-8. PubMed ID: 20172276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of intestinal stem cells and epithelium after alemtuzumab administration.
    Li Q; Zhang Q; Wang C; Jiang S; Li N; Li J
    Cell Mol Immunol; 2011 Jul; 8(4):325-32. PubMed ID: 21499290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+)8(+) mucosal T cells.
    Kumawat AK; Strid H; Elgbratt K; Tysk C; Bohr J; Hultgren Hörnquist E
    J Crohns Colitis; 2013 Oct; 7(9):694-705. PubMed ID: 22995775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of intestinal intraepithelial lymphocyte populations in experimental Trichinella spiralis infection of mice.
    Bozić F; Marinculić A; Duraković E
    Folia Parasitol (Praha); 2000; 47(1):55-9. PubMed ID: 10833017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alemtuzumab treatment of multiple sclerosis.
    Coles AJ
    Semin Neurol; 2013 Feb; 33(1):66-73. PubMed ID: 23709214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraepithelial gammadelta+ lymphocytes: a comparative study between celiac disease, small intestinal bacterial overgrowth, and irritable bowel syndrome.
    Remes-Troche JM; Adames K; Castillo-Rodal AI; Ramírez T; Barreto-Zuñiga R; López-Vidal Y; Uscanga LF
    J Clin Gastroenterol; 2007 Aug; 41(7):671-6. PubMed ID: 17667051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.
    Peleg AY; Husain S; Kwak EJ; Silveira FP; Ndirangu M; Tran J; Shutt KA; Shapiro R; Thai N; Abu-Elmagd K; McCurry KR; Marcos A; Paterson DL
    Clin Infect Dis; 2007 Jan; 44(2):204-12. PubMed ID: 17173218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.